How is a Fluorescence In Situ Hybridization (FISH) panel ordered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Order a FISH Panel

A FISH (Fluorescence In Situ Hybridization) panel is ordered through a laboratory requisition form that specifies the appropriate probe set for the clinical indication, along with proper specimen collection and handling requirements. 1

Ordering Process

Step 1: Determine Clinical Indication

  • Identify the specific clinical question (e.g., suspected chromosomal deletion, translocation, or gene rearrangement)
  • Common indications include:
    • Hematological malignancies (leukemia, multiple myeloma) 1
    • Solid tumors requiring specific genetic markers 1
    • Constitutional cytogenetic abnormalities 1
    • Prenatal diagnosis of chromosomal anomalies 1

Step 2: Select Appropriate FISH Panel

  • Choose a panel based on clinical suspicion:
    • Disease-specific panels (e.g., CLL panel with probes for 11q22.3, 13q14, chromosome 12 centromere, 17p13.1) 2
    • Multiple myeloma panel (e.g., 14q32, t(11;14), 13q14, 17p13.1) 1
    • Targeted single-gene probes for specific abnormalities 1

Step 3: Complete Laboratory Requisition

  • Include essential information:
    • Patient demographics
    • Clinical indication/suspected diagnosis
    • Specific FISH panel requested
    • Relevant clinical history
    • Physician contact information 1

Step 4: Specimen Collection

  • Collect appropriate specimen type:
    • Peripheral blood (heparin tube, not EDTA)
    • Bone marrow aspirate
    • Fresh tissue
    • Paraffin-embedded tissue sections (3-6 μm) 1
    • Amniotic fluid or chorionic villus sample (for prenatal testing) 1

Step 5: Specimen Handling

  • Follow specific handling requirements:
    • Maintain specimen at room temperature
    • Transport promptly to laboratory
    • For paraffin sections, ensure proper fixation and processing
    • For bone marrow/blood, use sodium heparin anticoagulant 1

Important Considerations

Specimen Quality Requirements

  • For hematologic malignancies, CD138+ cell enrichment may be required 1
  • For paraffin-embedded tissues, pathologist review of target area is recommended 1
  • Minimum cell count requirements vary by test type

Interpretation Guidelines

  • Analysis requirements:
    • Minimum of 100 interphase nuclei for diagnostic samples
    • Minimum of 200 interphase nuclei for follow-up studies 1
    • For metaphase FISH, at least 20 metaphases should be analyzed 1

Common Pitfalls to Avoid

  • Inadequate specimen collection or improper anticoagulant
  • Failure to specify the appropriate probe set
  • Insufficient clinical information to guide testing
  • Delayed transport affecting cell viability
  • Failure to recognize that FISH cannot detect all genetic abnormalities (e.g., point mutations) 1

Validation Requirements

  • Laboratories must validate each FISH probe before clinical use
  • Validation includes establishing:
    • Probe sensitivity and specificity
    • Normal cutoff values
    • Appropriate control samples 3

FISH testing is particularly valuable when conventional cytogenetics yields normal results, as it can detect clinically significant abnormalities with higher sensitivity, making it the preferred testing methodology for many hematologic disorders 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Fluorescence In Situ Hybridization Probe Validation for Clinical Use.

Methods in molecular biology (Clifton, N.J.), 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.